NOVEL BIOPOLYMERS FOR THE MEDICAL INDUSTRY

一种被称为聚合酶的生物催化剂将被用于生产 新型生物聚合物。这些聚合物的结构-性能关系 将确定哪些新材料可能在 生物医药产业。具体来说，在生物医学领域，这些小说 生物相容材料可能在如下应用中有用：受控 微囊给药；神经再生；伤口护理 作为抗粘连剂的缝合线和纱布、外科辅助物；骨板； 还有，治疗性靶向。研究目标包括准备小的 可被短链聚合酶转化的有机分子 从Zogloea ramigera到新的生物材料。后者随后将 被刻画出来。通过筛选一系列的有机小分子 应该可以创造出许多新的可生物降解的聚酯 医疗行业。

A biological catalyst, known as a polymerase will be used to manufacture new biopolymers. The structure-property relationships of these polymers will be determined to identify which new materials may be useful in the biomedical industry. Specifically, in the biomedical area these novel biocompatable materials may be useful in applications such as: controlled drug delivery using microcapsules; nerve regeneration; wound care as sutures and gauzes, surgical aids as anti-adhesion agents; bone plates; and, therapeutic targeting. The research goals involve preparing small organic molecules which may be converted, by the short-chain polymerase from Zoogloea ramigera into new biomaterials. The latter will subsequently be characterized. By screening a range of small organic molecules it should be possible to create many new biodegradable polyesters for the medical industry.